| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/26/2005 | EP1499306A2 Bicyclic amides |
| 01/26/2005 | EP1499186A1 Use of heme oxygenase-1 and products of heme degradation |
| 01/26/2005 | EP1427727B1 Compounds which inhibit the release of inflammatory cytokines |
| 01/26/2005 | EP1301514B1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/26/2005 | EP1248629B1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 01/26/2005 | EP1239867B1 Methods for treating and preventing damage to mucosal tissue |
| 01/26/2005 | EP1120409B1 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| 01/26/2005 | EP1084109B1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 01/26/2005 | EP1037604B1 Pharmaceutical aerosol compositions |
| 01/26/2005 | EP0944592B1 Vitamin d3 derivatives |
| 01/26/2005 | EP0854702B1 Antimicrobial compositions containing a c 3-c 6 alcohol |
| 01/26/2005 | CN1571796A Melanocortin receptor ligands |
| 01/26/2005 | CN1571794A Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 01/26/2005 | CN1571789A Himbacine analogues as thrombin receptor antagonists |
| 01/26/2005 | CN1571787A Quinuclidine derivatives processes for preparing them and their uses as M2 and/or M3 muscarinic receptor inhibitors |
| 01/26/2005 | CN1571781A 4-imidazolin-2-one compounds |
| 01/26/2005 | CN1571770A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/26/2005 | CN1571661A Taste masking spill-resistant formulation |
| 01/26/2005 | CN1571637A Use of cystathionine |
| 01/26/2005 | CN1569878A siRNA nucleic acid sequence for SARS coronavirus causing gene and its pharmaceutical use |
| 01/26/2005 | CN1569873A Antisense nucleic acid sequence for SARS coronavirus gene and its pharmaceutical use |
| 01/26/2005 | CN1569872A Antisense nucleic acid for inhibiting SARS virus gene expression and its use |
| 01/26/2005 | CN1569841A SARS coronavirus 3CL protease inhibitor and its use |
| 01/26/2005 | CN1569233A Method for manufacturing gene medicine for preventing and treating SARS and its medicinal prescription |
| 01/26/2005 | CN1569229A IgY product for resisting mouth and upper respiratory tract infection and its application |
| 01/26/2005 | CN1569228A SARS vaccine and its preparation method and application |
| 01/26/2005 | CN1569225A Recombinant human interferon alpha nebula |
| 01/26/2005 | CN1569223A Freeze-dried interferon spray and its preparation method |
| 01/26/2005 | CN1569220A Application of gene recombined anti fungus peptide in the treatment of eumycetes infection |
| 01/26/2005 | CN1569205A Method for preparing and controlling the quality of Chinese medicinal soft capsule |
| 01/26/2005 | CN1569192A Gorge caring tea and its preparing process |
| 01/26/2005 | CN1569182A Cocklebur fruit and magnolia flower contained ointment for treating chronic rhinitis and its preparing process |
| 01/26/2005 | CN1569169A 'Shuanghuanglian' effervescence tablet and its preparation |
| 01/26/2005 | CN1569153A Mint oil preparation for treating obstructive sleep apnea and low ventilation syndrome |
| 01/26/2005 | CN1569152A Preparation method of 'Watermelon Frost' |
| 01/26/2005 | CN1569151A Medicine for treating and preventing chronic obstructive pulmonary disease |
| 01/26/2005 | CN1569133A 'Shuanghuanglian' effervescence tablet and its preparation |
| 01/26/2005 | CN1569127A Compound preparation of purslane extraction and ginsenoside and its anti-anoxia usage |
| 01/26/2005 | CN1569102A Medicine for treating bronchodilatation |
| 01/26/2005 | CN1569094A Nasosinusitis treating medicinal pills |
| 01/26/2005 | CN1569084A Disturbing oil for preventing and treating SARS |
| 01/26/2005 | CN1569077A Medicine for treating laryngopharyngitis |
| 01/26/2005 | CN1569070A Medicine capable of relieving superficial pathologic factors to dissipate heat and soothing liver to normalize stomach function |
| 01/26/2005 | CN1569052A Medicine for killing SARS virus |
| 01/26/2005 | CN1569048A Novel method for preparing headache and vertigo treating medicine and its preparation |
| 01/26/2005 | CN1569016A Sustained release clarithromycin capsules and its preparation method |
| 01/26/2005 | CN1569010A Etimicin sulfate preparation and its preparing method |
| 01/26/2005 | CN1568992A Orally disintegrating tablet of loratadine and its preparation method |
| 01/26/2005 | CN1568984A Spray and aerosol for treating respiratory system disease and its preparing process |
| 01/26/2005 | CN1568973A Composition of vitamin C and arginine and its application |
| 01/26/2005 | CN1568970A Dripping pills of andrographolide and its preparing method |
| 01/26/2005 | CN1568968A Application of flavonol polyphenol in the preparing process of SARS treating medicine |
| 01/26/2005 | CN1568951A Pharmaceutical for preventing and curing acute gout, tumor and hepatic/pulmonary fibrosis and preparation method thereof |
| 01/26/2005 | CN1568949A Salbutamol Sulfate drop pills and preparation method thereof |
| 01/26/2005 | CN1568947A Bromhexine Hydrochloride drop pills and preparation method thereof |
| 01/26/2005 | CN1568945A Application of curcumin to preparation of pharmaceutical for SARS |
| 01/26/2005 | CN1186637C Use of chemotaxin-oid factor-1 in preparation of antibody with the action of curing inflammatory damage of organs |
| 01/26/2005 | CN1186318C Novel benzenesulphonamide compound, its prepn. process and medicinal compsns. contg. them |
| 01/26/2005 | CN1186095C Usage of clostridium toxin or its compound in the preparation process of Therapeutic agent snoring noises suppressing agent |
| 01/26/2005 | CN1186082C Medicine for treating acute plaryngitis, acute laryngitis and acute tonsillitis as well as its preparing method |
| 01/26/2005 | CN1186080C Laryngopharyngitis treating medicine |
| 01/26/2005 | CN1186051C Medicine for resolving phlegm and stopping cough and its preparing process |
| 01/26/2005 | CN1186048C Health tea for treating gynecopathy, urinary system and upper respiratory tract disease |
| 01/26/2005 | CN1186013C Peroral medicine deliver controlled system providing temporal and spatial control |
| 01/25/2005 | US6846958 Synthesis of benzimidate from benzoic acid |
| 01/25/2005 | US6846835 Treating chronic obstructive pulmonary disease, chronic bronchitis, asthma, chronic respiratory tract obstruction, fibroid lung, pulmonary emphysema or rhinitis |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
| 01/25/2005 | US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents |
| 01/25/2005 | US6846821 Tetrahydrothiopy ranphthalazinone derivatives as PDE4 inhibitors |
| 01/25/2005 | US6846811 For treating psoriasis, inflammation, leukemia, colon cancer, breast cancer or prostate cancer |
| 01/25/2005 | US6846799 Administering epidermal growth factor antagonist; blocking with antibody; chronic obstructive pulmonary disease |
| 01/25/2005 | US6846650 Nucleotide sequences coding polypeptide for use in the imaging, diagnosis, treatment classification and prevention of lung cancer |
| 01/25/2005 | US6846495 Respiratory system disorders; dextromethorphan in anhydrous solvents |
| 01/20/2005 | WO2005005424A1 Aztreonam l-lysine and methods for the preparation thereof |
| 01/20/2005 | WO2005004914A1 MEDICINAL COMPOSITION CONTAINING NF-κB DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME |
| 01/20/2005 | WO2005004913A1 Pharmaceutical composition containing decoy and method of using the same |
| 01/20/2005 | WO2005004875A1 Medicinal composition for pulmonary administration |
| 01/20/2005 | WO2005004865A1 Use of 5-ht4(a)-serotonin receptor agonists |
| 01/20/2005 | WO2005004852A1 Pharmaceutical formulations |
| 01/20/2005 | WO2005004639A1 Process for producing liquid formulation containing raw yeast and liquid formulation |
| 01/20/2005 | WO2004064742A9 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms |
| 01/20/2005 | WO2003076443A9 Spiro compounds with npy antagonistic activity |
| 01/20/2005 | WO2003066881A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/20/2005 | WO2003062392A3 Methods of treating conditions associated with an edg receptor |
| 01/20/2005 | WO2002050289A8 Methods for the production of multimeric proteins, and related compositions |
| 01/20/2005 | US20050014941 Cyanoalkylamino derivatives as protease inhibitors |
| 01/20/2005 | US20050014938 Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase |
| 01/20/2005 | US20050014931 A monoclonal antibody or an antigen-binding fragment thereof that specifically binds the capsular polysaccharide of Streptococcus pneumoniae serotype PPS 3; heavy chain amino acid sequence as well as DNA encoding it; complementary determining regions; pneumonia; passive immunizations; diagnosis/medical/ |
| 01/20/2005 | US20050014832 Treatment |
| 01/20/2005 | US20050014827 Formulations containing polyphenol derivatives; food and feed supplements; bactericidal, fungicidal and virucidal effects |
| 01/20/2005 | US20050014817 Fluorothiophene derivatives, process for preparing them and pharmaceutical compositions containing them |
| 01/20/2005 | US20050014816 Thiophene amino acid derivatives, process for preparing them and pharmaceutical compositions containing them |
| 01/20/2005 | US20050014795 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/20/2005 | US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
| 01/20/2005 | US20050014781 Ring fused pyrazole derivatives as CRF antagonists |
| 01/20/2005 | US20050014768 Antiinflammatory agents; analgesics |
| 01/20/2005 | US20050014762 Combination |
| 01/20/2005 | US20050014741 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 01/20/2005 | US20050014735 Therapy for autoimmune disease; antiallergens; antihistamines |